Michael W. Boyer

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk et al. · Journal of Clinical Oncology · 2017 · 318 citations · Full text

Life Sciences, Hematology, Immunology +16

Acute Lymphoblastic Leukemia, Version 2.2015

Joseph Alvarnas, Patrick A. Brown, Patricia Aoun et al. · Journal of the National Comprehensive Cancer Network · 2015 · 245 citations · Full text

Medicine, Hematology, Oncology +16

Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Patrick A. Brown, Bijal Shah, Anjali S. Advani et al. · Journal of the National Comprehensive Cancer Network · 2021 · 241 citations · Full text

Medicine, Oncology, Pediatrics +17

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia

Karen Thudium Mueller, Edward Waldron, Stephan A. Grupp et al. · Clinical Cancer Research · 2018 · 222 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells

Andrew M. Stein, Stephan A. Grupp, John E. Levine et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 146 citations · Full text

Life Sciences, Hematology, Immunology +17